Zydus secures USFDA approval for Cyclophosphamide Capsules, shares up
The shares of Zydus Lifesciences were up by 0.93 per cent to ₹643.00 at 2:26 pm on the BSE
The shares of Zydus Lifesciences were up by 0.93 per cent to ₹643.00 at 2:26 pm on the BSE